Vyalev - foscarbidopa/foslevodopa subcutaneous infusion for Parkinson's disease

Valeda Light Delivery System for age-related macular degeneration

Revumenib (Revuforj) for acute leukemia

Emrosi - low-dose, biphasic oral minocycline for rosacea

Dupilumab (Dupixent) for COPD

Seladelpar (Livdelzi) for primary biliary cholangitis

Qlosi - pilocarpine 0.4% ophthalmic solution for presbyopia

Drugs for age-related macular degeneration

Zanidatamab (Ziihera) for biliary tract cancer

Zenocutuzumab (Bizengri) for NSCLC and pancreatic adenocarcinoma

Isatuximab (Sarclisa) for multiple myeloma

Ribociclib (Kisqali) for early breast cancer

Zolbetuximab (Vyloy) for gastric and gastroesophageal carcinoma

In brief: New FDA warning of pulmonary aspiration with GLP-1 receptor agonists

Elafibranor (Iqirvo) for primary biliary cholangitis

Givinostat (Duvyzat) for Duchenne muscular dystrophy

Clonidine oral suspension (Onyda XR) for ADHD

Crexont - extended-release carbidopa/levodopa for Parkinson's disease

Comparison chart: Antiviral drugs for seasonal influenza for 2024-2025

In brief: Femlyv - an orally disintegrating hormonal contraceptive

In brief: Obecabtagene autoleucel (Aucatzyl) - another CAR-T cell immunotherapy for ALL